Browse > Article
http://dx.doi.org/10.22469/jkslp.2020.31.1.35

A Case of Thyroarytenoid Myectomy with Selective Recurrent Laryngeal Nerve Section in Intractable Spasmodic Dysphonia: A Long-Term Follow-Up  

Lee, Yun Ji (Department of Otorhinolaryngology-Head and Neck Surgery, Soonchunhyang University College of Medicine, Bucheon Hospital)
An, You Young (Department of Otorhinolaryngology-Head and Neck Surgery, Soonchunhyang University College of Medicine, Bucheon Hospital)
Park, Ki Nam (Department of Otorhinolaryngology-Head and Neck Surgery, Soonchunhyang University College of Medicine, Bucheon Hospital)
Lee, Seung Won (Department of Otorhinolaryngology-Head and Neck Surgery, Soonchunhyang University College of Medicine, Bucheon Hospital)
Publication Information
Journal of the Korean Society of Laryngology, Phoniatrics and Logopedics / v.31, no.1, 2020 , pp. 35-38 More about this Journal
Abstract
Spasmodic dysphonia is a disease presumed to be a form of focal laryngeal dystonia. The widely used first-line treatment is botulinum toxin injection to the thyroarytenoid muscles. In spite of the effectiveness and safety of this method, it has a temporary effect that lasts only several months, resulting the patients' symptom fluctuating, called 'Botox rollercoaster.' Some surgical techniques had tried, but they had shown several limitations including high rate of recurrence. We tried thyroarytenoid myectomy with selective recurrent laryngeal nerve section in a patient with intractable spasmodic dysphonia. This procedure is an alternative treatment of spasmodic dysphonia to prevent recurrence and improve symptoms. During five years of follow-up, she has shown steady quality voice without any complication. To the best of our knowledgement, this is the longest follow-up case of this operation in South Korea.
Keywords
Spasmodic dysphonia; Thyroarytenoid myectomy; Botulinum toxin injection;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Su CY, Chuang HC, Tsai SS, Chiu JF. Transoral approach to laser thyroarytenoid myoneurectomy for treatment of adductor spasmodic dysphonia: short-term results. Ann Otol Rhinol Laryngol 2007;116(1):11-8.   DOI
2 Blitzer A, Brin MF, Stewart CF. Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients. Laryngoscope 2015;125(8):1751-7.   DOI
3 Tsuji DH, Takahashi MT, Imamura R, Hachiya A, Sennes LU. Endoscopic laser thyroarytenoid myoneurectomy in patients with adductor spasmodic dysphonia: a pilot study on long-term outcome on voice quality. J Voice 2012;26(5):666.e7-12.   DOI
4 Berke GS, Blackwell KE, Gerratt BR, Verneil A, Jackson KS, Sercarz JA. Selective laryngeal adductor denervation-reinnervation: a new surgical treatment for adductor spasmodic dysphonia. Ann Otol Rhinol Laryngol 1999;108(3):227-31.   DOI
5 Isshiki N, Tsuji DH, Yamamoto Y, Iizuka Y. Midline lateralization thyroplasty for adductor spasmodic dysphonia. Ann Otol Rhinol Laryngol 2000;109(2):187-93.   DOI
6 Netterville JL, Stone RE, Rainey C, Zealear DL, Ossoff RH. Recurrent laryngeal nerve avulsion for treatment of spastic dysphonia. Ann Otol Rhinol Laryngol 1991;100(1):10-4.   DOI
7 Aronson AE, De Santo LW. Adductor spastic dysphonia: three years after recurrent laryngeal nerve resection. Laryngoscope 1983;93(1):1-8.   DOI
8 Su CY, Lai CC, Wu PY, Huang HH. Transoral laser ventricular fold resection and thyroarytenoid myoneurectomy for adductor spasmodic dysphonia: long-term outcome. Laryngoscope 2010;120(2):313-8.   DOI
9 Lee SJ, Jung SY, Chung SM, Kim HS. A case of thyroarytenoid myoneurectomy using laser and monopolar electrical device in spasmodic dysphonia. J Korean Soc Laryngol Phoniatr Logoped 2019;30(2):132-5.   DOI
10 Schonweiler R, Wohlfarth K, Dengler R, Ptok M. Supraglottal injection of botulinum toxin type A in adductor type spasmodic dysphonia with both intrinsic and extrinsic hyperfunction. Laryngoscope 1998;108(1 Pt 1):55-63.   DOI